URINARY VEGF Levels in GBM Patients on Radiation Treatmen... | NCT00392548

Studies
URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol

NCT00392548

Sponsor

Tel-Aviv Sourasky Medical Center

Status

Unknown status

Last Update Posted

Oct 26, 2006Estimated

Enrollment

130

Phase

Not provided

Conditions

Glioblastoma

Interventions

Not provided

Countries

Israel

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Sep 2006

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Not yet recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Oct 2006

Primary Completion Date

Not provided

Completion Date

Oct 2006

First Submitted Date

Oct 25, 2006

First Submission Date that Met QC Criteria

Oct 25, 2006

First Posted Date

Oct 26, 2006Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Oct 25, 2006

Last Update Posted Date

Oct 26, 2006Estimated

Name	Class
Radiation Therapy Oncology Group	NETWORK

Description Module

Brief Summary

Study of the urinary vascular endothelial growth factor (VEGF) levels in patients with glioblastoma, receiving standard therapy.

Hypothesis: that urinary VEGF levels can serve as a predictor of treatment response and survival.

Detailed Description

Measurement of urinary VEGF levels pre treatment,immediately after treatment, and 1 month after treatment

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

130

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Patient must be enrolled on an RTOG GBM study that prescribes 6000 cGy of radiation therapy.
Patient must meet the eligibility requirements for the RTOG treatment study. (If the patient is deemed retrospectively ineligible for the RTOG treatment study, the patient will likewise be ineligible for this study.)
Patient must sign a study-specific informed consent for RTOG 0611 prior to study entry.

Exclusion Criteria:

Patient not able to receive 6000 cGy of radiation therapy.

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Deborah T Blumenthal, MD	Contact	011972524266304		deborahblumenthal@gmail.com
Lina Vizelman, BS	Contact	01197236977532		linav@tasmc.health.gov.il

Overall Officials

Name	Affiliation	Role
Deborah T Blumenthal, MD	Tel-Aviv Sourasky Medical Center	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
tel Aviv Sourasky Medical Center		Tel Aviv		64239	Israel

Condition Browse Module

MeSH Terms

ID	Term
D005909	Glioblastoma

Ancestor Terms

ID	Term
D001254	Astrocytoma
D005910	Glioma
D018302	Neoplasms, Neuroepithelial
D017599	Neuroectodermal Tumors

Browse Leaves

Not provided

Browse Branches

Not provided